C. Patte, T. Philip, and C. Rodary, High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children., Journal of Clinical Oncology, vol.9, issue.1, pp.123-132, 1991.
DOI : 10.1200/JCO.1991.9.1.123

C. Patte, A. Auperin, and J. Michon, The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia, Blood, vol.97, issue.11, pp.3370-3379, 2001.
DOI : 10.1182/blood.V97.11.3370

C. Patte, A. Auperin, and M. Gerrard, of the randomized international FAB/LMB96 trial for intermediate risk B-cell non- Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients, Blood, vol.109, issue.7, pp.2773-2780, 2007.

T. Philip, O. Hartmann, and R. Pinkerton, Curability of relapsed childhood B-cell non- Hodgkin's lymphoma after intensive first line therapy: a report from the Société Française d'Oncologie Pédiatrique, Blood, vol.81, issue.8, pp.2003-2006, 1993.

M. Gerrard, M. Cairo, and C. Weston, Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin???s lymphoma: results of the FAB/LMB 96 international study, British Journal of Haematology, vol.2, issue.6, pp.840-847, 2008.
DOI : 10.1016/S0360-3016(01)02647-5

M. Cairo, M. Gerrard, and R. Sposto, Results of a randomized international study of high-risk central nervous system B non- Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents, Blood, vol.109, issue.7, pp.2736-2743, 2007.

A. Atra, M. Gerrard, R. Hobson, J. Imeson, I. Hann et al., Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols, British Journal of Haematology, vol.13, issue.4, pp.965-968, 2001.
DOI : 10.1046/j.1365-2141.2001.02647.x

T. Philip, P. Biron, and D. Maraninchi, Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non-Hodgkin's lymphoma, British Journal of Haematology, vol.937, issue.4, pp.599-609, 1985.
DOI : 10.1002/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2

R. Ladenstein, R. Pearce, O. Hartmann, C. Patte, T. Goldstone et al., High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry, Blood, vol.90, issue.8, pp.2921-2930, 1997.

N. Fujita, T. Mori, and T. Mitsui, The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: A retrospective analysis of enrolled cases in Japan, Pediatric Blood & Cancer, vol.15, issue.2, pp.188-192, 2008.
DOI : 10.1002/pbc.21585

P. Anoop, S. Sankpal, and C. Stiller, Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia, Leukemia & Lymphoma, vol.17, issue.10, pp.1882-1888, 2012.
DOI : 10.1002/pbc.21753

O. Hartmann, F. Pein, and F. Beaujean, High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas., Journal of Clinical Oncology, vol.2, issue.9, pp.979-985, 1984.
DOI : 10.1200/JCO.1984.2.9.979

O. Hartmann, E. Benhamou, and F. Beaujean, High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study., Journal of Clinical Oncology, vol.4, issue.12, pp.1804-1810, 1986.
DOI : 10.1200/JCO.1986.4.12.1804

H. Loiseau, O. Hartmann, and D. Valteau, High-dose chemotherapy containing busulfan followed by bone marrow transplantation in 24 children with refractory or relapsed non-Hodgkin's lymphoma, Bone Marrow Transplant, vol.8, issue.6, pp.465-472, 1991.

T. Gross, G. Hale, and W. He, Hematopoietic Stem Cell Transplantation for Refractory or Recurrent Non-Hodgkin Lymphoma in Children and Adolescents, Biology of Blood and Marrow Transplantation, vol.16, issue.2, pp.223-230, 2010.
DOI : 10.1016/j.bbmt.2009.09.021

H. Kim, E. Park, and S. Lee, Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents, Cancer Research and Treatment, vol.46, issue.4, pp.358-365, 2014.
DOI : 10.4143/crt.2013.047

M. Grossbard, J. Gribben, and A. Freedman, Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with Bcell non-Hodgkin's lymphoma, Blood, vol.81, issue.9, pp.2263-2271, 1993.

A. Bay, M. Dogan, M. Acikgoz, and A. Oner, Rituximab in a child with relapsed Burkitt lymphoma. Pediatr Blood Cancer, p.218, 2007.

D. Vries, M. Veerman, A. Zwaan, and C. , Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma, British Journal of Haematology, vol.101, issue.3, pp.414-415, 2004.
DOI : 10.1111/j.1365-2141.2004.04925.x

N. Kobrinsky, R. Sposto, and N. Shah, -Asparaginase, Maintenance Chemotherapy, and Transplantation: Children???s Cancer Group Study CCG-5912, Journal of Clinical Oncology, vol.19, issue.9
DOI : 10.1200/JCO.2001.19.9.2390

S. Won, J. Han, and S. Kwon, Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: a report from the Korean Society of Pediatric Hematology-Oncology

A. Attarbaschi, M. Dworzak, and M. Steiner, Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: A population-based analysis of the Austrian cooperative study group, Pediatric Blood & Cancer, vol.95, issue.1, pp.70-76, 2005.
DOI : 10.1002/pbc.20121

J. Sandlund, L. Bowman, and H. Heslop, Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL, Cytotherapy, vol.4, issue.3, pp.253-258, 2002.
DOI : 10.1080/146532402320219763

J. Gentet, C. Patte, and E. Quintana, Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology., Journal of Clinical Oncology, vol.8, issue.4, pp.661-665, 1990.
DOI : 10.1200/JCO.1990.8.4.661

M. Hertzberg, C. Crombie, W. Benson, J. Taper, D. Gottlieb et al., Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma, Annals of Oncology, vol.17, issue.suppl 4, pp.25-30, 2006.
DOI : 10.1093/annonc/mdj995

T. Kewalramani, A. Zelenetz, and S. Nimer, Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma, Blood, vol.103, issue.10, pp.3684-3688, 2004.
DOI : 10.1182/blood-2003-11-3911

T. Griffin, S. Weitzman, and H. Weinstein, A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: A report from the Children's Oncology Group, Pediatric Blood & Cancer, vol.94, issue.2, pp.177-181, 2009.
DOI : 10.1002/pbc.21753

C. Gisselbrecht, B. Glass, and N. Mounier, Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era, Journal of Clinical Oncology, vol.28, issue.27, pp.4184-4190, 2010.
DOI : 10.1200/JCO.2010.28.1618

S. Culi, V. Culi, V. Armanda, D. Kuljis, V. Pesuti-pisac et al., Anti-CD20 Monoclonal Antibody (Rituximab) for Therapy of Mediastinal CD20-Positive Large B-Cell Non-Hodgkin Lymphoma with a Local Tumor Extension into the Lung of a 10-Year-Old Girl, Pediatric Hematology and Oncology, vol.20, issue.4, pp.339-344, 2003.
DOI : 10.1080/08880010390203125

N. Schmitz, P. Dreger, B. Glass, and A. Sureda, Allogeneic transplantation in lymphoma: current status, Haematologica, vol.92, issue.11, pp.1533-1548, 2007.
DOI : 10.3324/haematol.11185

A. Grigg and J. Seymour, Graft versus Burkitt's Lymphoma Effect after Allogeneic Marrow Transplantation, Leukemia & Lymphoma, vol.62, issue.4, pp.889-892, 2002.
DOI : 10.1089/cbr.1997.12.177

R. Harris, A. Termuhlen, and L. Smith, Autologous Peripheral Blood Stem Cell Transplantation in Children with Refractory or Relapsed Lymphoma: Results of Children???s Oncology Group Study A5962, Biology of Blood and Marrow Transplantation, vol.17, issue.2, pp.249-258, 2011.
DOI : 10.1016/j.bbmt.2010.07.002

E. Sariban, B. Edwards, J. C. Magrath, and I. , Central nervous system involvement in American Burkitt's lymphoma., Journal of Clinical Oncology, vol.1, issue.11, pp.677-681, 1983.
DOI : 10.1200/JCO.1983.1.11.677

M. Cairo, R. Sposto, and M. Gerrard, Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (??? 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study, Journal of Clinical Oncology, vol.30, issue.4, pp.387-393, 2012.
DOI : 10.1200/JCO.2010.33.3369

A. Reiter and W. Klapper, Recent advances in the understanding and management of diffuse large B-cell lymphoma in children, British Journal of Haematology, vol.92, issue.Suppl. 1, pp.329-347, 2008.
DOI : 10.1111/j.1365-2141.2008.06988.x

A. Rosenwald and G. Ott, Burkitt lymphoma versus diffuse large B-cell lymphoma, Annals of Oncology, vol.19, issue.Supplement 4, pp.67-69, 2008.
DOI : 10.1093/annonc/mdn201

M. Cairo, R. Sposto, and J. Fan, Survival in children and adolescents with mature B- NHL progressing or relapsing from treatment on FAB/LMB 96: tumor burden and time to relapse are poor prognostic factors, Ped Blood Cancer, vol.855, 2009.